Upgrade to SI Premium - Free Trial

Landos Biopharma (LABP)

22.93 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

NImmune Biopharma Announces Presentations at Digestive Disease Week 2026 Supporting a Differentiated Profile and Superior Efficacy of Oral, Once-Daily NIM-1324 for IBD May 5, 2026 8:00 AM - BizWire NImmune Biopharma to Present Novel Mechanistic, Efficacy and Translational Data on LANCL2-Targeting Therapeutics Supporting Significant Pipeline-in-a-Drug Potential at IMMUNOLOGY2026 March 24, 2026 8:00 AM - BizWire Full Article List